Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH

Abstract

Mepartricin proved to be an effective treatment of benign prostatic hyperplasia, determining an improvement in symptoms, quality of life, and peak urinary flow.